R&D accounting treatment, firm performance, and market value: Biotech firms case study
Saved in:
| Main Author: | Namryoung Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centre of Sociological Research, Szczecin
2019-05-01
|
| Series: | Journal of International Studies |
| Subjects: | |
| Online Access: | https://www.jois.eu/?513,en_rd-accounting-treatment-firm-performance-and-market-value-biotech-firms-case-study |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Why and How the Value of Science-Based Firms Violates Financial Theory: Implications for Policy and Governance
by: Sergey Bredikhin, et al.
Published: (2017-03-01) -
Does halo effect of innovative firms moderate the impact of working capital efficiency on firm value? Evidence from India
by: Sayantan Kundu, et al.
Published: (2022-12-01) -
Intellectual Capital and Financial Performance of Biotech Companies in the Pharmaceutical Industry
by: Ion Anghel, et al.
Published: (2018-08-01) -
R&D Intensity, Complementary Assets and Firm Value: Time Series Evidence from Turkey
by: Kartal Demirgüneş, et al.
Published: (2020-06-01) -
The Impact of Vertical R&D Cooperation on Market Performance of Firms
by: Adam Karbowski, et al.
Published: (2019-12-01)